3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Completed
3
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Other
3
Gastrointestinal
1
Conditions
Obesity
45
Mucositis
29
Neoplasms
23
Sexual Dysfunction, Physiological
19
Head and Neck Neoplasms
16
Breast Neoplasms
16
Opioid-Induced Constipation
12
Dyspnea
11
Constipation
11
Pain
10
Polycystic Ovary Syndrome
9
Weight Loss
7
Squamous Cell Carcinoma of Head and Neck
7
Prostatic Neoplasms
7
Motor Activity
7
Diabetes Mellitus
7
Cardiovascular Diseases
6
Xerostomia
5
Stomatitis
5
Radiation Injuries
5
Overweight
5
Sedentary Behavior
4
Endometrial Neoplasms
4
Diabetes Mellitus, Type 2
4
Colorectal Neoplasms
4
Bronchiolitis Obliterans Syndrome
4
Sexuality
3
Salivary Gland Neoplasms
3
Hypertension
3
Fatty Liver
3
Interventions
penclomedine
1
Glucose Tolerance Test
1
Exenatide
1
Excitatory Amino Acids
1
Amino Acids, Essential
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Has results
×
Fatty Liver
×
Other
×
Clear all
NCT03717935
2025-03-24
ORANGE
University of Colorado, Denver
Phase NA
Completed
27 enrolled
15 charts
NCT02157974
2024-06-04
APPLE
University of Colorado, Denver
Phase 2/3
Completed
92 enrolled
17 charts
NCT03041129
2024-04-17
PLUM
University of Colorado, Denver
Completed
19 enrolled
10 charts